2014
DOI: 10.1016/j.bcmd.2013.10.008
|View full text |Cite
|
Sign up to set email alerts
|

Fluorescence in situ hybridization panel for monitoring of minimal residual disease in patients with double minute chromosomes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 12 publications
0
1
0
Order By: Relevance
“…For a long time, fluorescence in situ hybridization (FISH)-based approaches have been used to resolve amplified oncogenes linked with cancer development. However, FISH probes have been unable to discriminate the location of specific genes on chromosomal and extrachromosomal DNA molecules [ 157 ]. A more advanced cell-imaging technology, ecSeg [ 158 ], has been introduced to accurately quantify oncogene amplification from ecDNA at the single-cell level.…”
Section: Introductionmentioning
confidence: 99%
“…For a long time, fluorescence in situ hybridization (FISH)-based approaches have been used to resolve amplified oncogenes linked with cancer development. However, FISH probes have been unable to discriminate the location of specific genes on chromosomal and extrachromosomal DNA molecules [ 157 ]. A more advanced cell-imaging technology, ecSeg [ 158 ], has been introduced to accurately quantify oncogene amplification from ecDNA at the single-cell level.…”
Section: Introductionmentioning
confidence: 99%